Clinical Trial

Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings

Study acronym: PROFOUND
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Primary objective is to investigate the effectiveness of REKOVELLE® in women undergoing their first REKOVELLE® ovarian stimulation treatment in real world practice in Asian countries.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-08-16; most recent amendment 2026-02-16.
Status change: Recruiting → Active, Not Recruiting 2026-02-16
Status change: Not Yet Recruiting → Recruiting 2024-09-17
Trial Details
NCT Number NCT06561958
Lead Sponsor Ferring Pharmaceuticals
Conditions Infertility
Enrollment 1,500 participants
Start Date 2024-08-27
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-17